| Heidy Fernandez, CRNA | |
|
1400 Nw 12th Ave, Miami, FL 33136-1003 | |
| (305) 689-5376 | |
| Not Available |
| Full Name | Heidy Fernandez |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 15 Years |
| Location | 1400 Nw 12th Ave, Miami, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053550921 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | ARNP9234365 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Miami | 3274795109 | 1781 |
News Archive
While the debate over childhood obesity rumbles on and experts search for reasons for the epidemic, a clutch of new studies recently published suggests the causes are a combination of factors.
Columbia Laboratories, Inc. today announced that it has priced a transaction to raise up to approximately $11,772,000 through the sale of up to approximately 10,900,000 shares of its common stock and warrants to purchase 5,450,000 shares of its common stock in a registered direct offering. The common stock and warrants will be sold in units, with each unit consisting of one share of common stock and a warrant to purchase 0.5 shares of common stock.
EnVivo Pharmaceuticals today announced at the Alzheimer's Association 2010 International Conference on Alzheimer's Disease results from its proprietary gamma-secretase modulator pre-clinical study. In a transgenic mouse model, EnVivo's EVP-0015962 reduced amyloid plaque buildup which is believed to be a cause of Alzheimer's disease, reversed behavioral deficits and reduced brain inflammation associated with Alzheimer's disease.
Copper is an essential micronutrient that all organisms need to maintain healthy metabolism. But unless it is bound to proteins, copper is also toxic to cells. With a $1.3 million award from the National Institutes of Health, researchers at Worcester Polytechnic Institute will conduct a systematic study of copper in the bacteria Pseudomonas aeruginosa (P. aeruginosa), a leading cause of hospital-associated infections that is increasingly resistant to antibiotics, with the hope of discovering new drug targets that might allow cells in the body to use copper to fight back against this bacterial invader.
› Verified 9 days ago
| Entity Name | University Of Miami |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013967827 PECOS PAC ID: 3274795109 Enrollment ID: O20200406001006 |
News Archive
While the debate over childhood obesity rumbles on and experts search for reasons for the epidemic, a clutch of new studies recently published suggests the causes are a combination of factors.
Columbia Laboratories, Inc. today announced that it has priced a transaction to raise up to approximately $11,772,000 through the sale of up to approximately 10,900,000 shares of its common stock and warrants to purchase 5,450,000 shares of its common stock in a registered direct offering. The common stock and warrants will be sold in units, with each unit consisting of one share of common stock and a warrant to purchase 0.5 shares of common stock.
EnVivo Pharmaceuticals today announced at the Alzheimer's Association 2010 International Conference on Alzheimer's Disease results from its proprietary gamma-secretase modulator pre-clinical study. In a transgenic mouse model, EnVivo's EVP-0015962 reduced amyloid plaque buildup which is believed to be a cause of Alzheimer's disease, reversed behavioral deficits and reduced brain inflammation associated with Alzheimer's disease.
Copper is an essential micronutrient that all organisms need to maintain healthy metabolism. But unless it is bound to proteins, copper is also toxic to cells. With a $1.3 million award from the National Institutes of Health, researchers at Worcester Polytechnic Institute will conduct a systematic study of copper in the bacteria Pseudomonas aeruginosa (P. aeruginosa), a leading cause of hospital-associated infections that is increasingly resistant to antibiotics, with the hope of discovering new drug targets that might allow cells in the body to use copper to fight back against this bacterial invader.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Heidy Fernandez, CRNA 1400 Nw 12th Ave, Miami, FL 33136-1003 Ph: (305) 689-5376 | Heidy Fernandez, CRNA 1400 Nw 12th Ave, Miami, FL 33136-1003 Ph: (305) 689-5376 |
News Archive
While the debate over childhood obesity rumbles on and experts search for reasons for the epidemic, a clutch of new studies recently published suggests the causes are a combination of factors.
Columbia Laboratories, Inc. today announced that it has priced a transaction to raise up to approximately $11,772,000 through the sale of up to approximately 10,900,000 shares of its common stock and warrants to purchase 5,450,000 shares of its common stock in a registered direct offering. The common stock and warrants will be sold in units, with each unit consisting of one share of common stock and a warrant to purchase 0.5 shares of common stock.
EnVivo Pharmaceuticals today announced at the Alzheimer's Association 2010 International Conference on Alzheimer's Disease results from its proprietary gamma-secretase modulator pre-clinical study. In a transgenic mouse model, EnVivo's EVP-0015962 reduced amyloid plaque buildup which is believed to be a cause of Alzheimer's disease, reversed behavioral deficits and reduced brain inflammation associated with Alzheimer's disease.
Copper is an essential micronutrient that all organisms need to maintain healthy metabolism. But unless it is bound to proteins, copper is also toxic to cells. With a $1.3 million award from the National Institutes of Health, researchers at Worcester Polytechnic Institute will conduct a systematic study of copper in the bacteria Pseudomonas aeruginosa (P. aeruginosa), a leading cause of hospital-associated infections that is increasingly resistant to antibiotics, with the hope of discovering new drug targets that might allow cells in the body to use copper to fight back against this bacterial invader.
› Verified 9 days ago
Diego F Luna, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 900 Nw 17th St, Miami, FL 33136 Phone: 305-243-6411 | |
Ilene Ramirez, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 11750 Sw 40th Street, Miami, FL 33175 Phone: 305-223-4123 | |
Jenny Ivette Morales-sotomayor, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1100 Nw 95th St, Miami, FL 33150 Phone: 787-662-5032 Fax: 866-665-2702 | |
Jana Cabral, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1400 Nw 12th Ave Fl 3, Miami, FL 33136 Phone: 305-689-1338 Fax: 305-689-5791 | |
Beatriz R Acevedo, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1611 Nw 12 Avenue, Miami, FL 33136 Phone: 305-585-6586 | |
Ms. Gina Marie Corbett, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1611 Nw 12th Ave # C300, Miami, FL 33136 Phone: 305-585-6586 Fax: 305-585-5830 | |
Lucette Charles Baptiste, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1400 Nw 12th Ave, Miami, FL 33136 Phone: 305-689-5376 Fax: 305-689-3990 |